Savan S. Bhalodiya
Current Organizations / Institutes
The organizations/institutes from the scholar's latest article
Research Subjects
Savan S. Bhalodiya has a total of 29 co-authors. Here are the top co-authors by number of shared publications:
- Mehul P. Parmar
Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar, 388120, Gujarat, India
6 shared publications - Chirag D. Patel
Department of Chemistry, Sardar Patel University, Vallabh Vidyanagar, Near University Circle, Vallabh Vidyanagar-388120, Gujarat, India
5 shared publications - Disha P. Vala
Department of Chemistry, Sardar Patel University
5 shared publications - Hitendra M. Patel
Department of Chemistry Sardar Patel University Vallabh Vidyanagar Gujarat India
5 shared publications - Arijit Nandi
Department of Pharmacy Sanaka Educational Trust Group of Institutions (SETGOI) Durgapur West Bengal India
2 shared publications - Dipti B. Upadhyay
P. G. Department of Chemistry, Sardar Patel University, Near University Circle, Vallabh Vidyanagar, 388120, Gujarat, India
2 shared publications
Latest Publications
- Open Access
- 22 December 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (1) , 488-500
[BMIM]OAc promoted one-pot synthesis of pyrazolo[4′,3′:5,6]pyrido[2,3- d ]pyrimidin-5-ones and their antimicrobial activity
A one-pot method was developed for synthesizing pyrazolo[4′,3′:5,6]pyrido[2,3-d]pyrimidin-5-ones using the recyclable ionic liquid catalyst [BMIM]OAc in ethanol under reflux conditions. This approach achieved high yields (76–95%) across various substrates along with straightforward product isolation and catalyst recyclability. The synthesized compounds 4(a–l) were tested for antimicrobial activity against Gram-positive and Gram-negative bacteria, and fungal strains. Notably, compounds 4c and 4e showed strong antibacterial effects against S. aureus (MIC: 8 µg mL−1), while 4a, 4b, and 4f effectively inhibited E. coli (MIC: 8 µg mL−1). Compound 4l exhibited notable antifungal activity against C. albicans (MIC: 8 µg mL−1), outperforming the standard drugs. Cytotoxicity assessment on HEK293 cells revealed low toxicity in most derivatives (IC50 > 50 µM), with halogenated analogs (4c, 4e) displaying moderate activity but remaining less toxic than doxorubicin. Molecular docking and dynamics simulations confirmed stable interactions of key compounds (4c, 4e, 4f) with bacterial Tet repressor class D and fungal sterol 14-α demethylase, consistent with experimental data. Overall, this ionic liquid-catalyzed approach provides an efficient route to bioactive heterocycles with promising antimicrobial and anticancer potential.
- 22 December 2025
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 16 (1) , 488-500
Open Access[BMIM]OAc promoted one-pot synthesis of pyrazolo[4′,3′:5,6]pyrido[2,3- d ]pyrimidin-5-ones and their antimicrobial activity
A one-pot method was developed for synthesizing pyrazolo[4′,3′:5,6]pyrido[2,3-d]pyrimidin-5-ones using the recyclable ionic liquid catalyst [BMIM]OAc in ethanol under reflux conditions. This approach achieved high yields (76–95%) across various substrates along with straightforward product isolation and catalyst recyclability. The synthesized compounds 4(a–l) were tested for antimicrobial activity against Gram-positive and Gram-negative bacteria, and fungal strains. Notably, compounds 4c and 4e showed strong antibacterial effects against S. aureus (MIC: 8 µg mL−1), while 4a, 4b, and 4f effectively inhibited E. coli (MIC: 8 µg mL−1). Compound 4l exhibited notable antifungal activity against C. albicans (MIC: 8 µg mL−1), outperforming the standard drugs. Cytotoxicity assessment on HEK293 cells revealed low toxicity in most derivatives (IC50 > 50 µM), with halogenated analogs (4c, 4e) displaying moderate activity but remaining less toxic than doxorubicin. Molecular docking and dynamics simulations confirmed stable interactions of key compounds (4c, 4e, 4f) with bacterial Tet repressor class D and fungal sterol 14-α demethylase, consistent with experimental data. Overall, this ionic liquid-catalyzed approach provides an efficient route to bioactive heterocycles with promising antimicrobial and anticancer potential.
- 9 August 2025
- Published by Wiley in Chempluschem
- Vol. 90 (10) , e202500266
Room‐Temperature Accessible Stereospecific Synthesis of Methyl‐( Z )‐2‐(7‐methyl‐3‐oxo‐5 H ‐thiazolo[3,2‐ a ]pyrimidin‐2(3 H )‐ylidene)acetates:Cd 2+ Fluorescence Probe and DU145 Cell Study
Stereospecific synthesis of Methyl‐( Z )‐2‐(7‐methyl‐3‐oxo‐5 H ‐thiazolo[3,2‐ a ]pyrimidin‐2(3 H )‐ylidene)acetates 3 ( a– t ) is designed and explored their application as fluorescent probes for Cd 2+ ions for the first time. These analogs are synthesized via one‐pot reaction of (R/S)‐2‐thioxo‐3,4‐dihydropyrimidine‐5‐carboxanilides (TDHPM‐5‐carboxanilides) with dimethyl acetylenedicarboxylate in MeOH (methanol) as a reusable green solvent at room temperature (RT). Two new C(sp 2 )N, C(sp 2 )S sigma bonds, and one new C‐N π‐bond are formed during this transformation, achieving yields of up to 99%. This protocol demonstrates a low environmental factor (E‐factor) (0.09 to 0.35), high atom economy (94.83%), and carbon efficiency (142.68%), reflecting a significant advancement in green chemistry. Compound 3a is synthesized in 99% yield on a gram scale. Compound 3p proves to be an excellent fluorescent probe for Cd 2+ ions, showing a ninefold increase in fluorescence intensity. The limit of detection and limit of quantification for 3p with Cd 2+ ions are 7.5 and 25 μM, respectively, with an R 2 value of 0.9903. Density functional theory calculations revealed that Cd 2+ ions bind effectively in the cavity of 3p through a ligand‐to‐metal charge transfer mechanism. Cell viability assays and docking studies show that compounds 3g , 3h , 3p , and 3t exhibited potent activity against the DU145 prostate cancer cell line, with binding affinities of −7.7, −6.8, −8.1, and −7.5 kcal mol − 1 .
- 9 August 2025
- Published by Wiley in Chempluschem
- Vol. 90 (10) , e202500266
Room‐Temperature Accessible Stereospecific Synthesis of Methyl‐( Z )‐2‐(7‐methyl‐3‐oxo‐5 H ‐thiazolo[3,2‐ a ]pyrimidin‐2(3 H )‐ylidene)acetates:Cd 2+ Fluorescence Probe and DU145 Cell Study
Stereospecific synthesis of Methyl‐( Z )‐2‐(7‐methyl‐3‐oxo‐5 H ‐thiazolo[3,2‐ a ]pyrimidin‐2(3 H )‐ylidene)acetates 3 ( a– t ) is designed and explored their application as fluorescent probes for Cd 2+ ions for the first time. These analogs are synthesized via one‐pot reaction of (R/S)‐2‐thioxo‐3,4‐dihydropyrimidine‐5‐carboxanilides (TDHPM‐5‐carboxanilides) with dimethyl acetylenedicarboxylate in MeOH (methanol) as a reusable green solvent at room temperature (RT). Two new C(sp 2 )N, C(sp 2 )S sigma bonds, and one new C‐N π‐bond are formed during this transformation, achieving yields of up to 99%. This protocol demonstrates a low environmental factor (E‐factor) (0.09 to 0.35), high atom economy (94.83%), and carbon efficiency (142.68%), reflecting a significant advancement in green chemistry. Compound 3a is synthesized in 99% yield on a gram scale. Compound 3p proves to be an excellent fluorescent probe for Cd 2+ ions, showing a ninefold increase in fluorescence intensity. The limit of detection and limit of quantification for 3p with Cd 2+ ions are 7.5 and 25 μM, respectively, with an R 2 value of 0.9903. Density functional theory calculations revealed that Cd 2+ ions bind effectively in the cavity of 3p through a ligand‐to‐metal charge transfer mechanism. Cell viability assays and docking studies show that compounds 3g , 3h , 3p , and 3t exhibited potent activity against the DU145 prostate cancer cell line, with binding affinities of −7.7, −6.8, −8.1, and −7.5 kcal mol − 1 .
- Open Access
- 3 July 2025
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 297, 117914
Ethanol-mediated one-pot synthesis of 3-phenyl-3,4,5,12-tetrahydrobenzo[4,5]imidazo[2,1-b]quinazolin-1(2H)-ones as PDGFRA inhibitors
- 3 July 2025
- Published by Elsevier in European Journal of Medicinal Chemistry
- Vol. 297, 117914
Open AccessEthanol-mediated one-pot synthesis of 3-phenyl-3,4,5,12-tetrahydrobenzo[4,5]imidazo[2,1-b]quinazolin-1(2H)-ones as PDGFRA inhibitors
- 13 November 2024
- Published by Wiley in ChemMedChem
- Vol. 20 (2) , e202400595
Acetic Acid‐Driven One‐Pot Synthesis of 4,7‐dihydro‐[1,2,3]thiadiazolo[5,4‐b]pyridine‐6‐carboxamides and Pharmacological Evaluations
A diverse set of 4,7‐dihydro‐[1,2,3]thiadiazolo[5,4‐b]pyridine‐6‐carboxamides 4(a–o) was synthesized via a one‐pot reaction of 5‐amino‐[1,2,3]thiadiazole, various aromatic aldehydes, and different acetoacetanilides, using glacial acetic acid. The resulting compounds were obtained in moderate to good yields. All the newly synthesized compounds were evaluated for their antimicrobial activity. Among them, compound 4 e demonstrated superior efficacy against the Salinivibrio proteolyticus strain of Gram‐negative bacteria compared to ciprofloxacin. Compound 4 d exhibited the highest potency against the fungal strain Candida albicans, surpassing amphotericin B. The physicochemical characteristics of 4 d and 4 e were assessed. According to docking analysis, DHTDAPy 4 e shows a higher binding affinity of −7.2 kcal/mol in the binding cavity of the receptor. These findings illustrate the safety, tolerability, and potency of the newly synthesized DHTDAPy compounds against fungal and bacterial infections.
- 13 November 2024
- Published by Wiley in ChemMedChem
- Vol. 20 (2) , e202400595
Acetic Acid‐Driven One‐Pot Synthesis of 4,7‐dihydro‐[1,2,3]thiadiazolo[5,4‐b]pyridine‐6‐carboxamides and Pharmacological Evaluations
A diverse set of 4,7‐dihydro‐[1,2,3]thiadiazolo[5,4‐b]pyridine‐6‐carboxamides 4(a–o) was synthesized via a one‐pot reaction of 5‐amino‐[1,2,3]thiadiazole, various aromatic aldehydes, and different acetoacetanilides, using glacial acetic acid. The resulting compounds were obtained in moderate to good yields. All the newly synthesized compounds were evaluated for their antimicrobial activity. Among them, compound 4 e demonstrated superior efficacy against the Salinivibrio proteolyticus strain of Gram‐negative bacteria compared to ciprofloxacin. Compound 4 d exhibited the highest potency against the fungal strain Candida albicans, surpassing amphotericin B. The physicochemical characteristics of 4 d and 4 e were assessed. According to docking analysis, DHTDAPy 4 e shows a higher binding affinity of −7.2 kcal/mol in the binding cavity of the receptor. These findings illustrate the safety, tolerability, and potency of the newly synthesized DHTDAPy compounds against fungal and bacterial infections.
- Open Access
- 14 March 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (13) , 9300-9313
A green bio-organic catalyst (taurine) promoted one-pot synthesis of (R/S)-2-thioxo-3,4-dihydropyrimidine(TDHPM)-5-carboxanilides: chiral investigations using circular dichroism and validation by computational approaches
Twenty-three new derivatives of (R/S)-TDHPM-5-carboxanilide have been synthesized with up to 99% yield. All racemates were separated using chiral HPLC (Prep LC) which provided up to 99.99% purity. AC was determined using circular dichroism spectra.
- 14 March 2024
- Published by Royal Society of Chemistry (RSC) in RSC Advances
- Vol. 14 (13) , 9300-9313
Open AccessA green bio-organic catalyst (taurine) promoted one-pot synthesis of (R/S)-2-thioxo-3,4-dihydropyrimidine(TDHPM)-5-carboxanilides: chiral investigations using circular dichroism and validation by computational approaches
Twenty-three new derivatives of (R/S)-TDHPM-5-carboxanilide have been synthesized with up to 99% yield. All racemates were separated using chiral HPLC (Prep LC) which provided up to 99.99% purity. AC was determined using circular dichroism spectra.
- Open Access
- 11 January 2024
- Published by Elsevier in Results in Chemistry
- Vol. 7, 101304
Cs2CO3-promoted one-pot synthesis of novel tetrahydrobenzofuran-4(2H)-ones: In vitro antimicrobial, antimalarial activity and in silico docking study
- 11 January 2024
- Published by Elsevier in Results in Chemistry
- Vol. 7, 101304
Open AccessCs2CO3-promoted one-pot synthesis of novel tetrahydrobenzofuran-4(2H)-ones: In vitro antimicrobial, antimalarial activity and in silico docking study